Correlation Between Alnylam Pharmaceuticals, and TechnipFMC Plc

Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals, and TechnipFMC Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals, and TechnipFMC Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alnylam Pharmaceuticals, and TechnipFMC plc, you can compare the effects of market volatilities on Alnylam Pharmaceuticals, and TechnipFMC Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals, with a short position of TechnipFMC Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals, and TechnipFMC Plc.

Diversification Opportunities for Alnylam Pharmaceuticals, and TechnipFMC Plc

0.84

Correlation Coefficient

Alnylam Pharmaceuticals,  TechnipFMC Plc

Very poor diversification

The 3 months correlation between Alnylam and TechnipFMC is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals, and TechnipFMC plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TechnipFMC plc and Alnylam Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals, are associated (or correlated) with TechnipFMC Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TechnipFMC plc has no effect on the direction of Alnylam Pharmaceuticals, i.e., Alnylam Pharmaceuticals, and TechnipFMC Plc go up and down completely randomly.

Pair Corralation between Alnylam Pharmaceuticals, and TechnipFMC Plc

Assuming the 90 days trading horizon Alnylam Pharmaceuticals, is expected to generate 0.82 times more return on investment than TechnipFMC Plc. However, Alnylam Pharmaceuticals, is 1.22 times less risky than TechnipFMC Plc. It trades about 0.26 of its potential returns per unit of risk. TechnipFMC plc is currently generating about 0.07 per unit of risk. If you would invest  6,995  in Alnylam Pharmaceuticals, on April 23, 2025 and sell it today you would earn a total of  1,579  from holding Alnylam Pharmaceuticals, or generate 22.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Alnylam Pharmaceuticals,  vs.  TechnipFMC plc

Alnylam Pharmaceuticals,

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Alnylam Pharmaceuticals, are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, Alnylam Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

TechnipFMC plc

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in TechnipFMC plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, TechnipFMC Plc may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Alnylam Pharmaceuticals, and TechnipFMC Plc

The main advantage of trading using opposite Alnylam Pharmaceuticals, and TechnipFMC Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals, position performs unexpectedly, TechnipFMC Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TechnipFMC Plc will offset losses from the drop in TechnipFMC Plc's long position.

The idea behind Alnylam Pharmaceuticals, and TechnipFMC plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.